-
effectivehealthcare-admin.ahrq.gov/sites/default/files/mcda_webinar_transcript2.pdf
August 27, 2012 - Before we begin I would like to set the stage for why we
felt this was an important webcast to host. … minutes at the end. … I will be
discussing the use of analytic hierarchy process, the stage
of which was set very nicely … The gain for going from five
months to ten months in progression free survival in renal
cell carcinoma … specific question for you, Reed, is how
do you manage to get patient input on things like treatment
for renal
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/bladder-cancer-non-muscle-invasive_executive.pdf
October 01, 2015 - were no clear differences between fluorescent
cystoscopy and white light cystoscopy in the risk of
renal … tumor stage. … Fluorescent
vs. white light
cystoscopy:
renal and
genitourinary
adverse events
Low There were no … clear differences between
fluorescent cystoscopy and white light
cystoscopy in risk of renal and genitourinary … Surveillance, Epidemiology and End
Results Program: Turning Cancer Data Into Discovery.
-
effectivehealthcare-admin.ahrq.gov/products/predictors-trauma-care/research-protocol
December 01, 2019 - several additional factors such as age, prior conditions (e.g., anticoagulation and bleeding disorders, end-stage … renal disease, pregnancy >20 weeks), burns with or without trauma, and EMS judgement and recommends … The end points or "outcomes" of interest are the predictive utility of the measures. … ("tissue oxygen saturation" or "end-tidal" or "lactate").mp. … ("tissue oxygen saturation" or "end-tidal" or "lactate").mp.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/dietary-supplements_research-protocol.pdf
December 15, 2010 - aminotransferase [AST], alanine aminotransferase [ALT],
alkaline phosphatase [ALP], or hepatitis)
o Renal … disease, with known cardiovascular disease; participants with diabetes; participants with
hepatic or renal … dysfunction or end-stage renal disease; participants taking a cardiovascular drug for an
indication … Key Informants
Key Informants are the end users of research, including patients and caregivers, practicing … Because of their role as end-users, individuals
are invited to serve as Key Informants and those who
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/bladder-cancer-muscle-invasive_disposition-comments.pdf
June 30, 2015 - included
was carboplatin/gemcitabine as
chemotherapy. while this is commonly used
for those with renal … compared to
no or limited PLND Q3b – SWOG 8710 did
report a significant benefit when risk
stratified by stage … SWOG 8710 (Grossman et
al) found no interaction
between tumor stage and
effects of treatment, as … Between 1/2014
and the end of 2015 there has been and
will be more new data now with respect to
biomarkers
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/plasma-cell-dyscrasias-sflc-assay-future_research.pdf
September 01, 2012 - o Studies of only patients with disease reflects the extreme end of the spectrum of
disease severity … o Studies of only patients with disease reflects the extreme end of the spectrum of
disease severity … Serum free light chain
measurements move to center stage. … Treatment of acute renal failure secondary to
multiple myeloma with chemotherapy and
extended high … Failure Due to Myeloma Cast Nephropathy
Recruiting Chronic renal
failure with uremic
nephropathy
-
effectivehealthcare-admin.ahrq.gov/products/venous-ulcers-treatment/research-protocol
December 01, 2019 - antibiotics (KQ 2)
Allergic and hypersensitivity reactions
Drug toxicity (not allergic)
Major—renal … Key Informants
Key Informants are the end-users of research, including patients and caregivers, practicing … Because of their role as end-users, individuals are invited to serve as Key Informants and those who … daily doses
Aminoglycosides
Gentamicin, tobramycin, amikacin
Can be dosed once daily
Major renal … toxicity; requires close monitoring of dose, drug levels, renal function
Table 3
Table 3
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/predictors-trauma-care_research-protocol.pdf
May 31, 2017 - several additional factors such as age, prior conditions (e.g.,
anticoagulation and bleeding disorders, end-stage … renal disease, pregnancy>20 weeks),
burns with or without trauma, and EMS judgement and recommends … such as
complexity/variability of heart rate, tissue O2 saturation, mean arterial pressure, lactate,
end-tidal … limited to respiration rate, tissue O2 saturation,
respiratory effort, measure of acidemia (e.g., end-tidal … The end points or “outcomes” of interest are the predictive utility of the measures.
-
effectivehealthcare-admin.ahrq.gov/products/medication-therapy-management/research-protocol
December 01, 2019 - 2013, this criterion includes at least five of nine core chronic conditions—Alzheimer’s disease and end-stage … renal disease were the added conditions. … Because of the stage of the science in this area, we anticipate that the benefit from conducting a systematic … pressure; total, low-density lipoprotein, or high-density lipoprotein cholesterol; pulmonary function; renal … Because of their role as end-users, individuals are invited to serve as Key Informants, and those who
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/hepatitis-c_executive.pdf
November 01, 2012 - refers to the
cross-linking of polyethylene glycol molecules to the
interferon molecule, which delays renal … harms differ according to patient subgroup
characteristics, including HCV genotype, age, race,
sex, stage … performed in groups stratified
by HCV genotype as well as by race, age, body weight,
viral load, stage … improvement in measures related to quality of life (generic or
disease-specific) 24 weeks after the end … Low
bid = twice daily; CI = confidence interval; ESLD = end-stage liver disease; HCC = hepatocellular
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/venous-ulcers-treatment_research-protocol.pdf
September 13, 2012 - Major—renal toxicity, hepatic toxicity, gastrointestinal upset
c. … Source: www.effectivehealthcare.ahrq.gov
Published Online: September 13, 2012
Key Informants are the end-users … Because of their role as end-users,
individuals are invited to serve as Key Informants and those who … multiple daily doses
Aminoglycosides Gentamicin, tobramycin,
amikacin
Can be dosed once daily Major renal … toxicity; requires close
monitoring of dose, drug levels, renal
function
Abbreviations: C. diff
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/medication-therapy-management_research-protocol.pdf
January 01, 2014 - 2013, this criterion
includes at least five of nine core chronic conditions—Alzheimer’s disease and end-stage … renal
disease were the added conditions. … Because of the stage of the science in this area, we anticipate
that the benefit from conducting a systematic … pressure; total, low-density lipoprotein, or high-density lipoprotein cholesterol;
pulmonary function; renal … Because of their role as end-users,
individuals are invited to serve as Key Informants, and those who
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/diabetes-update-2015_executive.pdf
January 01, 2015 - include
the microvascular complications of
retinopathy and blindness, neuropathy,
nephropathy, and end-stage … pressure and heart rate, and for
studies that include a comparison with SGLT-2 inhibitors,
impaired renal … The exclusion criteria were generally similar for most
trials: significant renal, cardiovasular, and … rosiglitazone and
pioglitazone, are contraindicated in patients with serious
or severe heart failure (Stage … 3 or Stage 4) according to
product labels.54, 55
We had low or insufficient strength of evidence for
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/hepatitis-c-screening_disposition-comments.pdf
November 27, 2012 - With such a large population
progressing toward end-stage liver disease we need to find these people … needlessly suffer and our healthcare system
will be further overburdened and, frankly, overrun, with end-stage … screening becomes irrelevant because a substantial proportion of HCV
patients will have developed end-stage … Stage Renal Disease. … I have seen many many hospitalized patients with end stage liver disease who are alcoholics
AND have
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/machine-learning-quality_research.pdf
September 01, 2012 - While adherence improved, many patients still
failed to receive 100% indicated treatments at the end … Health care institutions struggle with the challenge of
providing excellent palliative and end-of-life … BACKGROUND: High quality end-of-life care in the community is achieved with effective
multidisciplinary … BACKGROUND: Chronic renal failure and haemodialysis treatment is a long-term process;
patients need … become established in partnership working; the collaborative
approach to providing palliative care for end-stage
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/measuring-blood-pressure-surveillance-160412.pdf
April 11, 2016 - Effects"on"office"and"home"blood"pressure"
of"the"lercanidipine'enalapril"combination"in"patients"with"Stage … Blood"pressure"changes"after"renal"denervation"at"10"European"expert"
centers." … Abstracts"from"relevant"literature"are"included"at"the"end"of"the"attached"
document." … $Abstracts$are$provided$for$included$literature$at$the$end$of$
the$document.$
Conclusions(From(Original … Usual(Care:(
Clinical(Outcomes(
SOE:(Insufficient(
(
One$quality$C$study$reported$
on$mortality$and$end"stage
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/hepatitis-c-treatment-future_research.pdf
April 01, 2013 - refers to the cross-linking of
polyethylene glycol molecules to the interferon molecule, which delays renal … improvement in measures related to quality of life (generic
or disease-specific) 24 weeks after the end … Low
Note: CI=confidence interval, ESLD=end-stage liver disease, HCC=hepatocellular carcinoma, HCV=hepatitis … week 8
Alanine aminotransferase and aspartate aminotransferase
normalization: in normal range at end … in relation to Interleukin 28B (IL28-b) expression
Incidence of anemia
Response rate (rapid/early/end
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/hepatitis-c_surveillance.pdf
December 01, 2015 - Excluded: Pregnant women, HIV co-infected, transplant recipients, patients with
renal failure
Interventions … Abstracts from relevant literature are included at the end of
the attached document. … Abstracts are provided for included literature at the end of the document. … No trials reported harms in patients stratified by factors such as HCV genotype, age,
race, sex, stage … response; RR = relative risk; HCV-RNA = hepatitis c virus-ribonucleic acid; BMI = body mass index; ESLD = end-stage
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/hepatitis-c_surveillance.pdf
December 01, 2015 - Excluded: Pregnant women, HIV co-infected, transplant recipients, patients with
renal failure
Interventions … Abstracts from relevant literature are included at the end of
the attached document. … Abstracts are provided for included literature at the end of the document. … No trials reported harms in patients stratified by factors such as HCV genotype, age,
race, sex, stage … response; RR = relative risk; HCV-RNA = hepatitis c virus-ribonucleic acid; BMI = body mass index; ESLD = end-stage
-
effectivehealthcare-admin.ahrq.gov/products/diabetes-behavior-programs/research-protocol
December 01, 2019 - glucose regulation; medication adherence; or self-monitoring for diabetic complications (foot, eye and renal … glucose awareness, medication adherence, or self-monitoring for diabetic complications (foot, eye, and renal … propose the following time points, but will seek input from the TEP to confirm their appropriateness: end … Key Informants
Key informants are the end users of research, including patients and caregivers, practicing … Because of their role as end-users, individuals are invited to serve as key informants and those who